The Intervention Effect Of Alpha-Ketoglutarate On Abdominal Aortic Aneurysm Progression and Rupture: A Prospective, Randomized Parallel Controlled Study Based On Large Cohorts

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this project is to define whether nutritional supplement (oral administration with alpha-ketoglutarate) capable of filling-up the citric acid cycle (anaplerotic therapy) can improve outcomes in patients with an abdominal aortic aneurysm of 39-49 mm in diameter on ultrasound imaging. Alpha-ketoglutarate is commonly used as a nutritional supplement specially by athletes to increase muscle strength. They can be mixed with formula or other foods. Subjects will be followed for up to 5 years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:

• Presence of an infrarenal AAA with a maximum diameter of 39-49 mm;

• Han nationality;

• Between 50 years or more, no gender limit;

• No mental illness;

• No history of supplement allergy or supplement allergy;

• Subjects voluntarily participate in this study, sign an informed consent form, have good compliance, and cooperate with follow-up.

Locations
Other Locations
China
Cardiology, Ren Ji Hospital
RECRUITING
Shanghai
Contact Information
Primary
Jun Pu
pujun310@hotmail.com
86-21-68383477
Time Frame
Start Date: 2021-02-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 300
Treatments
Experimental: alpha-ketoglutarate Group
Take alpha-ketoglutarate supplements, alpha-ketoglutarate 300mg/d mixed with food or drink, for 1 years
No_intervention: Normal Control Group
Don't take alpha-ketoglutarate supplements
Sponsors
Leads: RenJi Hospital

This content was sourced from clinicaltrials.gov